// App-Quantinova.ai

2594 : Mechanism of Systemic Iron Regulation and Hematocrit Control By Hepcidin Peptidomimetics in Pre-Clinical Models

Researchers

Presenter

  • Roopa Taranath

Principal Investigators

  • Larry Mattheakis

  • Li Zhao

  • Larry Lee

  • James Tovera

  • Jingsong Zhao

  • Xiaoli Cheng

  • David Liu

Medical Centers

  • Protagonist Therapeutics, Newark, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Hemochromatosis 1

  • Polycythemia vera

  • Hemochromatosis

  • Venous thrombosis

Biomarkers

  • Cytoglobin

  • Hematocrit

  • TIMP Metallopeptidase Inhibitor 1

  • Red Blood Cells

Drug/Treatment

  • Erythropoietin

Outcome

  • N/A

Study Design

  • Pharmacodynamics

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved